Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki and approved by the ethic committee of the CHU de Québec-Université Laval. The clinical study (2017–3228) was approved on 20 December 2016 and the proteomics study (2022–6092) was approved on 1 November 2021.